By Brenden BobbyReader Columnist You’ve probably heard the catchy jingles for Ozempic, a miracle weight loss drug that has ...

GLP-1 weight loss drugs are proving beneficial for people struggling with obesity and diabetes, but there is another surprising side effect coming to light.

U.S. drug maker Eli Lilly & Co. is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

Several common drugs will be cheaper next year under Medicare, from weight-loss drug Ozempic to breast-cancer medication ...

Geneticist Michael Klotsman was frustrated by human drug development. That led him to launch a startup focused on treatments ...

Real-world data show semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) are linked with lower risk of major ...

Despite the widespread popularity of new weight-loss medications, research suggests a non-drug alternative is significantly ...

Affordable Semaglutide and Tirzepatide programs start at $249/month with free assessment, fast doctor review, and discreet home delivery. STAFFORD, VA / ACCESS Newswire / December 17, 2025 / ...

As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...

A new logo, typeface and dedicated GLP-1 medical program follow the company filing for bankruptcy in May following subscriber ...